Nurse-led Integrated Care in COPD Patients With a Pulmonary Exacerbation

Not Applicable

Completed

• Conditions: COPD Exacerbation
• Interventions: Other: Integrated Care Model

• Registration Number: NCT04011332
• Lead Sponsor: University of Zurich

Brief Summary

The aim of the study is to evaluate the effect and effectiveness of the nurse-led integrated care programme for the management of COPD (Chronic Obstructive Pulmonary Disease) exacerbations on patients' quality of life, rehospitalisation and exacerbation rate, illness-related emotional distress, selected health behaviours and cost-utility at three months. Furthermore, understanding barriers and facilitators to implementation success is of interest.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-04
• Study First Submitted: 2019-07-04
• Study First Submitted QC: 2019-07-04
• Study First Posted: 2019-07-08
• Primary Completion: 2023-03-30
• Study Completion: 2023-04-30
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-10
• Last Update Posted: 2023-05-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 69

Inclusion Criteria

• Patients with a confirmed diagnosis of COPD (GOLD 1-4)
• Hospitalisation due to a COPD exacerbation and decision to start with steroids and/or antibiotics (severe exacerbation)
• Age ≥ 18

Exclusion Criteria

• Cognitive impairment (dementia, delirium)
• Not speaking German, French, Italian, English, Spanish, Portuguese, Serbian, Tamil, Hindi, Turkish or Slovakian

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Arm && Interventions

Group	Intervention	Description
Intervention Group	Integrated Care Model	-

Primary Outcome Measures

Name	Time	Method
Change in CRQ (Chronic Respiratory Questionnaire) scores	at week one and week 13	Change in the four CRQ (Chronic Respiratory Questionnaire) subscores from week 1 to 13. The self-administered questionnaire version with standardised dyspnea questions (SAS) will be used. The questionnaire was developed for patients with chronic airflow limitations and comprises 20 items which assess four domains: 1) dyspnea, 2) fatigue, 3) emotional function and 4) mastery. The scoring scale ranges from 1 (extreme) to 7 (not at all) and will be assessed with a recall period of the past 2 weeks. A subscore for each domain (sum of items / number of items) will be calculated.

Trial Locations

Locations (1)

University Hospital Zurich; 🇨🇭 Zürich, Switzerland